Population pharmacokinetic modelling of total and unbound cefazolin plasma concentrations as a guide for dosing in preterm and term neonates
Author(s) -
Roosmarijn F. W. De Cock,
Anne Smits,
Karel Allegaert,
Jan de Hoon,
Veroniek Saegeman,
Meindert Danhof,
Catherijne A. J. Knibbe
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkt527
Subject(s) - dosing , cefazolin , pharmacokinetics , medicine , population pharmacokinetics , population , pharmacology , antibiotics , anesthesia , biology , microbiology and biotechnology , environmental health
Cefazolin is frequently administered for antimicrobial prophylaxis and treatment of infections. In neonates, pharmacokinetic observations are limited and dosing regimens variable. The aim of this study was to describe the pharmacokinetics of cefazolin in neonates based on total and unbound concentrations to optimize cefazolin dosing.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom